Cargando…

Upadacitinib for rheumatoid arthritis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572193/
https://www.ncbi.nlm.nih.gov/pubmed/33093749
http://dx.doi.org/10.18773/austprescr.2020.053
_version_ 1783597293810745344
collection PubMed
description
format Online
Article
Text
id pubmed-7572193
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-75721932020-10-21 Upadacitinib for rheumatoid arthritis Aust Prescr New Drugs NPS MedicineWise 2020-08-06 2020-10 /pmc/articles/PMC7572193/ /pubmed/33093749 http://dx.doi.org/10.18773/austprescr.2020.053 Text en (c) NPS MedicineWise http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Upadacitinib for rheumatoid arthritis
title Upadacitinib for rheumatoid arthritis
title_full Upadacitinib for rheumatoid arthritis
title_fullStr Upadacitinib for rheumatoid arthritis
title_full_unstemmed Upadacitinib for rheumatoid arthritis
title_short Upadacitinib for rheumatoid arthritis
title_sort upadacitinib for rheumatoid arthritis
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572193/
https://www.ncbi.nlm.nih.gov/pubmed/33093749
http://dx.doi.org/10.18773/austprescr.2020.053